264 related articles for article (PubMed ID: 21603275)
1. Relationships of adrenoceptor polymorphisms with obesity.
Masuo K; Lambert GW
J Obes; 2011; 2011():609485. PubMed ID: 21603275
[TBL] [Abstract][Full Text] [Related]
2. Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.
Masuo K
Int J Hypertens; 2010 Oct; 2010():832821. PubMed ID: 20981286
[TBL] [Abstract][Full Text] [Related]
3. Adrenoceptor Polymorphisms in Hypertension and Diabetes with obesity-update in 2014.
Masuo K
Curr Hypertens Rev; 2014 Aug; ():. PubMed ID: 25115695
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
[TBL] [Abstract][Full Text] [Related]
5. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
7. The peripheral sympathetic nervous system in human obesity.
van Baak MA
Obes Rev; 2001 Feb; 2(1):3-14. PubMed ID: 12119635
[TBL] [Abstract][Full Text] [Related]
8. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
9. Signalling in body-weight homeostasis: neuroendocrine efferent signals.
Webber J; Macdonald IA
Proc Nutr Soc; 2000 Aug; 59(3):397-404. PubMed ID: 10997655
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta(2)-adrenoceptor gene polymorphisms on diet-induced thermogenesis.
Oomen JM; Waijers PM; van Rossum C; Hoebee B; Saris WH; van Baak MA
Br J Nutr; 2005 Nov; 94(5):647-54. PubMed ID: 16277765
[TBL] [Abstract][Full Text] [Related]
12. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
13. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
14. Acute β-adrenoceptor mediated glucose clearance in brown adipose tissue; a distinct pathway independent of functional insulin signaling.
Olsen JM; Åslund A; Bokhari MH; Hutchinson DS; Bengtsson T
Mol Metab; 2019 Dec; 30():240-249. PubMed ID: 31767175
[TBL] [Abstract][Full Text] [Related]
15. β
Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
[TBL] [Abstract][Full Text] [Related]
16. Role of β
Leblanc C; Tabrizchi R
Eur J Pharmacol; 2018 Jan; 819():136-143. PubMed ID: 29208473
[TBL] [Abstract][Full Text] [Related]
17. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
Horinouchi T; Koike K
J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363
[TBL] [Abstract][Full Text] [Related]
18. Effects of nutrient intake on sympathoadrenal activity and thermogenic mechanisms.
Astrup AV; Christensen NJ; Simonsen L; Bülow J
J Neurosci Methods; 1990 Sep; 34(1-3):187-92. PubMed ID: 2259241
[TBL] [Abstract][Full Text] [Related]
19. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats.
Berg T; Piercey BW; Jensen J
Hypertension; 2010 May; 55(5):1224-30. PubMed ID: 20231523
[TBL] [Abstract][Full Text] [Related]
20. Regulation of beta 3-adrenoceptor expression in white fat cells.
Langin D; Tavernier G; Lafontan M
Fundam Clin Pharmacol; 1995; 9(2):97-106. PubMed ID: 7628838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
